Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 161

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Review article: thiopurines in inflammatory bowel disease

Open access
DERIJKS, L. J. J., GILISSEN, L. P. L., HOOYMANS, P. M., HOMMES, D. W. · 2006 · Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: In the past 10–20 years, knowledge of both thiopurine pharmacology and ‐pharmacogenetics has been extended dramatically and used to develop new strategies to improve efficacy and reduce toxicity. Aim: To review thiopurine efficacy, toxicity, pharmacology, pharmacogenetics, interactions in patients with inflammatory bowel disease. Special attention was paid to new strategies for optimization of pharmacotherapy. Methods: To collect relevant scientific articles, a Pubmed search was performed from 1966 through January 2006 with the following key words (MeSH terms preferentially) in multiple combinations: ‘azathioprine’, ‘6‐mercaptopurine’, ‘6‐MP’, ‘6‐thioguanine’, ‘6‐TG’, ‘thiopurine(s)’, ‘metabolites’, ‘level(s)’, ‘TDM’, ‘TMPT’, ‘ITPA’, ‘genotype(s)’, ‘phenotype(s)’, ‘inflammatory bowel disease’, ‘Crohn(’s) disease’, ‘ulcerative colitis’. Results: Strategies for optimization of pharmacotherapy include therapeutic drug monitoring of thiopurine metabolites, geno‐ or phenotyping crucial enzymes in thiopurine metabolism like thiopurine S‐methyltransferase and inosine triphosphate pyrophosphatase, and the use of thioguanine as such. Conclusions: Thiopurine S‐methyltransferase genotyping and therapeutic drug monitoring are useful instruments for individualizing thiopurine pharmacotherapy of inflammatory bowel disease. Inosine triphosphate pyrophosphatase genotyping may be helpful in case of unexplainable myelotoxicity. In case of azathioprine‐ or mercaptopurine‐intolerance, thioguanine seems a promising alternative. However, more knowledge needs to be gathered about its potential hepatotoxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2006.02980.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 161

Metadata

Authors
DERIJKS, L. J. J., GILISSEN, L. P. L., HOOYMANS, P. M., & HOMMES, D. W.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2006-08-16
Volume
24
Issue
5
Pages
715-729
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2132433180
Cited by
161
References
1
FWCI
6.89
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review article: thiopurines in inflammatory bowel disease. https://app.cochat.ai/papers/10.1111/j.1365-2036.2006.02980.x
The paper
DERIJKS, L. J. J., GILISSEN, L. P. L., HOOYMANS, P. M., & HOMMES, D. W. (2006). Review article: thiopurines in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2006.02980.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.